CS
GSK icon

Comerica Securities’s GSK GSK Stock Holding History

Comerica Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-176
Closed -$6.24K – 853
2022
Q4 		$6.24K Buy
+176
New +$5.86K ﹤0.01% 1092
2020
Q4 		– Sell
-9,350
Closed -$446K – 485
2020
Q3 		$446K Sell
9,350
-1,667
-15% -$83.5K 0.04% 293
2020
Q2 		$569K Sell
11,017
-2,101
-16% -$108K 0.05% 249
2020
Q1 		$632K Sell
13,118
-798
-6% -$42.6K 0.07% 219
2019
Q4 		$826K Buy
13,916
+903
+7% +$50.2K 0.08% 229
2019
Q3 		$702K Buy
13,013
+523
+4% +$26.9K 0.07% 239
2019
Q2 		$625K Buy
12,490
+828
+7% +$41.5K 0.07% 239
2019
Q1 		$617K Buy
11,662
+1,275
+12% +$63.7K 0.07% 239
2018
Q4 		$502K Buy
10,387
+261
+3% +$12.9K 0.07% 247
2018
Q3 		$515K Sell
10,126
-1,246
-11% -$63.3K 0.06% 270
2018
Q2 		$580K Buy
11,372
+486
+4% +$24.5K 0.07% 248
2018
Q1 		$540K Sell
10,886
-1,207
-10% -$56.2K 0.07% 254
2017
Q4 		$543K Buy
12,093
+955
+9% +$44.1K 0.07% 257
2017
Q3 		$571K Buy
11,138
+2,550
+30% +$129K 0.08% 238
2017
Q2 		$467K Buy
8,588
+1,546
+22% +$82.4K 0.07% 256
2017
Q1 		$371K Buy
7,042
+1,177
+20% +$59.7K 0.06% 283
2016
Q4 		$282K Sell
5,865
-1,946
-25% -$96.1K 0.12% 183
2016
Q3 		$421K Sell
7,811
-395
-5% -$21.7K 0.18% 126
2016
Q2 		$445K Buy
8,206
+3,352
+69% +$177K 0.22% 105
2016
Q1 		$246K Buy
4,854
+376
+8% +$18.7K 0.13% 161
2015
Q4 		$226K Buy
4,478
+256
+6% +$13K 0.14% 160
2015
Q3 		$203K Buy
+4,222
New +$220K 0.12% 175

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Comerica Securities's GSK Position: Q1 2023 in Review

Comerica Securities sold out of GSK (GSK) in Q1 2023, closing a stake of 176 shares — an estimated $6.24K sold.

Comerica Securities first reported a position in GSK in Q3 2015 and held it in 22 quarters. The position peaked at $826K in Q4 2019. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Comerica Securities reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 176 GSK shares in Q1 2023, an estimated $6.24K.
  • Comerica Securities first reported a position in GSK in Q3 2015 and held it in 22 quarters.
  • Comerica Securities's GSK position peaked at $826K in Q4 2019.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.